Vanda Pharmaceuticals
VNDA
#7861
Rank
HK$2.47 B
Marketcap
HK$41.96
Share price
3.65%
Change (1 day)
12.81%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : HK$2.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has HK$2.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$2.90 B-4.08%
2023-12-31HK$3.03 B-16.87%
2022-12-31HK$3.64 B8.08%
2021-12-31HK$3.37 B18.38%
2020-12-31HK$2.85 B17.27%
2019-12-31HK$2.43 B20.62%
2018-12-31HK$2.01 B79.87%
2017-12-31HK$1.12 B2.23%
2016-12-31HK$1.09 B-1.24%
2015-12-31HK$1.10 B10.21%
2014-12-31HK$1.00 B-0.38%
2013-12-31HK$1.01 B8.31%
2012-12-31HK$0.93 B-19.29%
2011-12-31HK$1.15 B-24.97%
2010-12-31HK$1.54 B-3.18%
2009-12-31HK$1.59 B343.39%
2008-12-31HK$0.35 B-45.94%
2007-12-31HK$0.66 B167.92%
2006-12-31HK$0.24 B2.62%
2005-12-31HK$0.24 B91.16%
2004-12-31HK$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
HK$75.92 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$77.17 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.49 B 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.46 B 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.64 B 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
HK$21.82 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.78 B 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA